Clinical Trials · NCT07173712
Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Yanbing Li
- Enrollment
- 324
- Start date
- Mar 2026
- Locations
- See registry
- Primary endpoint
- Proportion of subjects with optimal glycemic control